Search
State of Possible: On the one-year anniversary of the spin-out of Seaport Therapeutics, Daphne Zohar describes the Glyph platform that powers it, and her thoughts on running depression trials
She describes the idea of leveraging Glyph to achieve oral dosing of medicines in cases where it would not be possible or tolerable....
Mar 26
Biotech CEO Sisterhood: A leadership series discussion on building an effective board, best practices for running meetings, hiring talent, and decision making
Sisterhood editorial board members Daphne Zohar (Seaport Therapeutics) and Luba Greenwood (Gallop Oncology) share their experiences about...
Jan 6
Daphne Zohar on becoming the CEO of Seaport Therapeutics and today's $100M series A
She describes working with Steven Paul again, the Glyph technology that is the backbone of Seaport's platform, and more.
Apr 9, 2024
Daphne Zohar shares the history of the founding of Karuna and the business model of PureTech
The founder and CEO of PureTech talks about Karuna, and PureTech's business model of having a wholly owned pipeline plus founded entities.
Jan 8, 2024
.png){kind=logo}
